Elsevier

Experimental Neurology

Volume 171, Issue 1, September 2001, Pages 29-45
Experimental Neurology

Regular Article
Involvement of Microglial Receptor for Advanced Glycation Endproducts (RAGE) in Alzheimer's Disease: Identification of a Cellular Activation Mechanism

https://doi.org/10.1006/exnr.2001.7732Get rights and content

Abstract

Receptor-mediated interactions with amyloid β-peptide (Aβ) could be important in the evolution of the inflammatory processes and cellular dysfunction that are prominent in Alzheimer's disease (AD) pathology. One candidate receptor is the receptor for advanced glycation endproducts (RAGE), which can bind Aβ and transduce signals leading to cellular activation. Data are presented showing a potential mechanism for Aβ activation of microglia that could be mediated by RAGE and macrophage colony-stimulating factor (M-CSF). Using brain tissue from AD and nondemented (ND) individuals, RAGE expression was shown to be present on microglia and neurons of the hippocampus, entorhinal cortex, and superior frontal gyrus. The presence of increased numbers of RAGE-immunoreactive microglia in AD led us to further analyze RAGE-related properties of these cells cultured from AD and ND brains. Direct addition of Aβ(1–42) to the microglia increased their expression of M-CSF. This effect was significantly greater in microglia derived from AD brains compared to those from ND brains. Increased M-CSF secretion was also demonstrated using a cell culture model of plaques whereby microglia were cultured in wells containing focal deposits of immobilized Aβ(1–42). In each case, the Aβ stimulation of M-CSF secretion was significantly blocked by treatment of cultures with anti-RAGE F(ab′)2. Treatment of microglia with anti-RAGE F(ab′)2 also inhibited the chemotactic response of microglia toward Aβ(1–42). Finally, incubation of microglia with M-CSF and Aβ increased expression of RAGE mRNA. These microglia also expressed M-CSF receptor mRNA. These data suggest a positive feedback loop in which Aβ–RAGE-mediated microglial activation enhances expression of M-CSF and RAGE, possibly initiating an ascending spiral of cellular activation.

References (73)

  • S. Haga et al.

    Synthetic Alzheimer amyloid beta/A4 peptides enhance production of complement C3 component by cultured microglial cells

    Brain Res.

    (1993)
  • M.A. Hofmann et al.

    RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100/calgranulin polypeptides

    Cell

    (1999)
  • O. Hori et al.

    The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin: Mediation of neurite outgrowth and co- expression of rage and amphoterin in the developing nervous system

    J. Biol. Chem.

    (1995)
  • S. Itagaki et al.

    Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease

    J. Neuroimmunol.

    (1989)
  • A.R. Korotzer et al.

    Cultured rat microglia express C1q and receptor for C1q: Implications for amyloid effects on microglia

    Exp. Neurol.

    (1995)
  • Y.M. Kuo et al.

    Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains

    J. Biol. Chem.

    (1996)
  • J. Li et al.

    Sp1-binding elements in the promoter of RAGE are essential for amphoterin-mediated gene expression in cultured neuroblastoma cells

    J. Biol. Chem.

    (1998)
  • J. Li et al.

    Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products

    J. Biol. Chem.

    (1997)
  • D. Lorton et al.

    Chemotactic-like receptors and Abeta peptide induced responses in Alzheimer's disease

    Neurobiol. Aging

    (2000)
  • L.F. Lue et al.

    Characterization of glial cultures from rapid autopsies of Alzheimer's and control patients

    Neurobiol. Aging

    (1996)
  • L.F. Lue et al.

    Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

    Am. J. Pathol.

    (1999)
  • E.G. McGeer et al.

    The importance of inflammatory mechanisms in Alzheimer disease

    Exp. Gerontol.

    (1998)
  • G. Munch et al.

    Advanced glycation endproducts in ageing and Alzheimer's disease

    Brain Res. Rev.

    (1997)
  • G.M.J. Murphy et al.

    Macrophage colony-stimulating factor augments beta-amyloid-induced interleukin-1, interleukin-6, and nitric oxide production by microglial cells

    J. Biol. Chem.

    (1998)
  • G.M.J. Murphy et al.

    Expression of macrophage colony-stimulating factor receptor is increased in the AbetaPP(V717F) transgenic mouse model of Alzheimer's disease

    Am. J. Pathol.

    (2000)
  • G.M Pasinetti

    Inflammatory mechanisms in neurodegeneration and Alzheimer's disease: The role of the complement system

    Neurobiol. Aging

    (1996)
  • N. Sasaki et al.

    Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases

    Am. J. Pathol.

    (1998)
  • M. Stalder et al.

    Association of microglia with amyloid plaques in brains of APP23 transgenic mice

    Am. J. Pathol.

    (1999)
  • S.D. Styren et al.

    Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain

    Exp. Neurol.

    (1990)
  • L.J. Van Eldik et al.

    S100 beta expression in Alzheimer's disease: Relation to neuropathology in brain regions

    Biochim. Biophys. Acta

    (1994)
  • F.L. Van Muiswinkel et al.

    The amino-terminus of the amyloid-beta protein is critical for the cellular binding and consequent activation of the respiratory burst of human macrophages

    J. Neuroimmunol.

    (1999)
  • D.G. Walker et al.

    Expression of the proto-oncogene Ret, a component of the GDNF receptor, persists in human substantia nigra neurons in Parkinsons's disease

    Brain Res.

    (1998)
  • J. Wegiel et al.

    Reduced number and altered morphology of microglial cells in colony stimulating factor-1-deficient osteopetrotic op/op mice

    Brain Res.

    (1998)
  • S.D. Yan et al.

    Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins

    J. Biol. Chem.

    (1994)
  • M. Abel et al.

    Expression of receptors for advanced glycosylated end-products in renal disease

    Nephrol. Dial. Transplant.

    (1995)
  • K.T. Akama et al.

    Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanism

    Proc. Natl. Acad. Sci. USA

    (1998)
  • Cited by (0)

    1

    These two authors contributed to this paper equally.

    2

    To whom correspondence and reprint requests should be addressed at Sun Health Research Institute, 10515 West Santa Fe Drive, Sun City, AZ 85351. Fax: (623) 876 5481. E-mail: [email protected].

    3

    Present address: Department of Biochemistry, Biophysics and Molecular Biology, Iowa State University, Ames, IA 50011.

    View full text